Manifestaciones musculoesqueléticas de la diabetes mellitus

Altas du diabète de la FID (8e édition) 2017. www.idf.org. Wang, 2012, Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival, Am J Cardiol, 110 Haddad A, Timsit MA. La main du diabétique. Journées d’enseignement organisées par l’URAM de l’hôpital Lariboisière, 2000. p. 69–81. Crispin, 2003, Rheumatologic manifestations of diabetes mellitus, Am J Med, 114, 753, 10.1016/S0002-9343(03)00140-2 Arkkila, 2003, Musculoskeletal disorders in diabetes mellitus: an update, Best Pract Res Clin Rheumatol, 17, 945, 10.1016/j.berh.2003.11.001 Silva, 2012, Musculoskeletal disorders in diabetes mellitus, Rev Bras Reumatol, 52, 601, 10.1590/S0482-50042012000400010 Serban, 2012, Rheumatic manifestations in diabetic patients, J Med Life, 5, 252 Abourazzak, 2014, Articular and abarticular manifestations in type 2 diabetes mellitus, Eur J Rheumatol, 1, 132, 10.5152/eurjrheumatol.2014.140050 Rosenbloom, 1981, Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease, N Engl J Med, 305, 191, 10.1056/NEJM198107233050403 Attar, 2012, Musculoskeletal manifestations in diabetic patients at a tertiary center, Libyan J Med, 7, 10.3402/ljm.v7i0.19162 Grgic, 1976, Joint contracture, common manifestation of childhood diabetes mellitus, J Pediatr, 88, 584, 10.1016/S0022-3476(76)80011-X Clarke, 1990, Limited joint mobility in children and adolescents with insulin dependent diabetes mellitus, Ann Rheum Dis, 49, 236, 10.1136/ard.49.4.236 Aljahlan, 1999, Limited joint mobility in diabetes. Diabetic cheiroarthropathy may be a clue to more serious complications, Postgrad Med, 105, 99, 10.3810/pgm.1999.02.536 Cagliero, 2002, Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus, Am J Med, 112, 487, 10.1016/S0002-9343(02)01045-8 Hurst, 2009, Injectable collagenase Clostridium histolyticum for Dupuytren's contracture, N Engl J Med, 361, 968, 10.1056/NEJMoa0810866 Gulliford, 2006, Increased incidence of carpal tunnel syndrome up to 10 years before diagnosis of diabetes, Diabetes Care, 29, 1929, 10.2337/dc06-0939 Fatemi, 2015, Musculoskeletal manifestations in diabetic versus prediabetic patients, Int J Rheum Dis, 18, 791, 10.1111/1756-185X.12712 Singla, 2015, Musculoskeletal effects of diabetes mellitus, J Pak Med Assoc, 65, 1024 Ergen, 2013, Charcot foot in diabetes and an update on imaging, Diabet Foot Ankle, 4, 10.3402/dfa.v4i0.21884 La Fontaine, 2016, Current concepts of Charcot foot in diabetic patients, Foot, 26, 7, 10.1016/j.foot.2015.11.001 Rajbhandari, 2002, Charcot neuroarthropathy in diabetes mellitus, Diabetologia, 45, 1085, 10.1007/s00125-002-0885-7 Chisholm, 2011, The Charcot joint: a modern neurologic perspective, J Clin Neuromuscul Dis, 13, 1, 10.1097/CND.0b013e3181c6f55b Schneekloth, 2016, Charcot neuroarthropathy in patients with diabetes: an updated systematic review of surgical management, J Foot Ankle Surg, 55, 586, 10.1053/j.jfas.2015.12.001 Varma, 2013, Charcot neuroarthropathy of the foot and ankle: a review, J Foot Ankle Surg, 52, 740, 10.1053/j.jfas.2013.07.001 Wukich, 2016, Prevalence of peripheral arterial disease in patients with diabetic Charcot neuroarthropathy, J Foot Ankle Surg, 55, 727, 10.1053/j.jfas.2016.01.051 Peterson, 2017, Diagnostic imaging of diabetic foot disorders, Foot Ankle Int, 38, 86, 10.1177/1071100716672660 Armstrong, 2017, Diabetic foot ulcers and their recurrence, N Engl J Med, 376, 2367, 10.1056/NEJMra1615439 Womack, 2017, Charcot arthropathy versus osteomyelitis: evaluation and management, Orthop Clin North Am, 48, 241, 10.1016/j.ocl.2016.12.011 Rozzanigo, 2009, Role of magnetic resonance imaging in the evaluation of diabetic foot with suspected osteomyelitis, Radiol Med, 114, 121, 10.1007/s11547-008-0337-7 Clokie, 2017, New horizons in the understanding of the causes and management of diabetic foot disease: report from the 2017 Diabetes UK Annual Professional Conference Symposium, Diabet Med, 34, 305, 10.1111/dme.13313 Boulton, 2000, The diabetic foot Gnanasegaran, 2012, Diagnosis of infection in the diabetic foot using (18)F-FDG PET/CT: a sweet alternative?, Eur J Nucl Med Mol Imaging, 39, 1525, 10.1007/s00259-012-2234-5 Palestro, 2009, Labeled leukocyte imaging: current status and future directions, Q J Nucl Med Mol Imaging, 53, 105 Palestro, 2009, Radionuclide imaging of infection: in search of the grail, J Nucl Med, 50, 671, 10.2967/jnumed.108.058297 Palestro, 2009, Nuclear medicine and diabetic foot infections, Semin Nucl Med, 39, 52, 10.1053/j.semnuclmed.2008.08.006 Palestro, 1998, Marrow versus infection in the Charcot joint: indium-11 leucocyte and technetium-99m Sulfur colloid scintigraphy, J Nucl Med, 39, 346 Palestro, 2011, 18F-FDG and diabetic foot infections: the verdict is…, J Nucl Med, 52, 1009, 10.2967/jnumed.111.087478 Basu, 2007, Potential role of FDG PET in the setting of diabetic neuroosteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?, Nucl Med Commun, 28, 465, 10.1097/MNM.0b013e328174447f Basu, 2009, Positron emission tomography as a diagnostic tool in infection: present role and future possibilities, Semin Nucl Med, 39, 36, 10.1053/j.semnuclmed.2008.08.004 Rastogi, 2016, Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy, Nucl Med Commun, 37, 1253, 10.1097/MNM.0000000000000603 Fautrel, 2004, Le pied diabétique, 67 Eichenholtz, 1966 Sanders, 1991, Diabetic neuropathic osteoarthropathy: The Charcot foot, 297 Giurini, 1991, Charcot's disease in diabetic patients, Postgrad Med, 89, 163, 10.1080/00325481.1991.11700869 Brodsky, 1993, The diabetic foot, 278 Herbst, 2004, Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density, J Bone Joint Surg Br, 86, 378, 10.1302/0301-620X.86B3.14593 Rogers, 2008, Imaging of the Charcot foot, Clin Podiatr Med Surg, 25, 263, 10.1016/j.cpm.2008.01.002 Rogers, 2013, The Charcot foot, Med Clin North Am, 97, 847, 10.1016/j.mcna.2013.04.003 Chantelau, 2013, The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging: a review of 71 cases, Swiss Med Wkly, 143, W13831 Chantelau, 2014, Is the Eichenholtz classification still valid for the diabetic Charcot foot?, Swiss Med Wkly, 144, W13948 Fujii, 2013, Efficacy of magnetic resonance imaging in diagnosing diabetic foot osteomyelitis in the presence of ischemia, J Foot Ankle Surg, 52, 717, 10.1053/j.jfas.2013.07.009 Milne, 2013, Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review, J Foot Ankle Res, 6, 30, 10.1186/1757-1146-6-30 Lipsky, 2012, Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. 2012 Infectious Diseases Society of America, Clin Infect Dis, 54, e132, 10.1093/cid/cis346 Palermo, 2017, Pathophysiology of bone fragility in patients with diabetes, Calcif Tissue Int, 100, 122, 10.1007/s00223-016-0226-3 Antonopoulou, 2013, Diabetes and bone health, Bone, 56, 355 Starup-Linde, 2015, Management of endocrine disease: diabetes and osteoporosis: cause for concern?, Eur J Endocrinol, 173, R93, 10.1530/EJE-15-0155 Hygum, 2017, Mechanisms in endocrinology: diabetes mellitus, a state of low bone turnover – a systematic review and meta-analysis, Eur J Endocrinol, 176, R137, 10.1530/EJE-16-0652 Vestergaard, 2007, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis, Osteoporos Int, 18, 427, 10.1007/s00198-006-0253-4 Cohen-Solal, 2008, Diabète et ostéoporose, 272 Moayeri, 2017, Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis, Ther Clin Risk Manag, 13, 455, 10.2147/TCRM.S131945 Napoli, 2017, Mechanisms of diabetes mellitus-induced bone fragility, Nat Rev Endocrinol, 13, 208, 10.1038/nrendo.2016.153 Napoli, 2014, Fracture risk in diabetic elderly men: the MrOS study, Diabetologia, 57, 2057, 10.1007/s00125-014-3289-6 Miyake, 2017, Decreased serum insulin-like growth factor-I is a risk factor for non-vertebral fractures in diabetic postmenopausal women, Intern Med, 56, 269, 10.2169/internalmedicine.56.7416 Russo, 2016, Fracture risk in type 2 diabetes: current perspectives and gender differences, Int J Endocrinol, 2016, 1615735, 10.1155/2016/1615735 Yamamoto, 2009, Diabetic patients have an increased risk of vertebral fractures independent of bone mineral density or diabetic complications, J Bone Miner Res, 24, 702, 10.1359/jbmr.081207 Ardawi, 2013, Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes, Bone, 56, 355, 10.1016/j.bone.2013.06.029 Moyer-Mileur, 2008, IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes, J Bone Miner Res, 23, 1884, 10.1359/jbmr.080713 Kanazawa, 2007, Serum insulin-like growth factor I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus, Osteoporosis Int, 18, 1675, 10.1007/s00198-007-0430-0 Buckingham, 1990, Relationship between the content of lysyl oxidase-dependent cross-links in skin collagen, non enzymatic glycosylation and long term complications in type 1 diabetes mellitus, J Clin Invest, 86, 1046, 10.1172/JCI114807 Zhao, 2017, The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms, Front Endocrinol, 8, 98, 10.3389/fendo.2017.00098 Starup-Linde, 2017, Use of glucose-lowering drugs and risk of fracture in patients with type 2 diabetes, Bone, 95, 136, 10.1016/j.bone.2016.11.026 Schwartz, 2006, Thiazolidinedione use and bone loss in older diabetic adults, J Clin Endocrinol Metab, 91, 3349, 10.1210/jc.2005-2226 Grey, 2007, The peroxisome proliferator-activated receptor-γ agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial, J Clin Endocrinol Metab, 92, 1305, 10.1210/jc.2006-2646 Yaturu, 2007, Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men, Diabetes Care, 30, 1574, 10.2337/dc06-2606 Kahn, 2008, Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT), Diabetes Care, 31, 845, 10.2337/dc07-2270 Starup-Linde, 2017, Epidemiology of fractures in diabetes, Calcif Tissue Int, 100, 109, 10.1007/s00223-016-0175-x Sato, 2016, Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database, BMC Musculoskelet Disord, 17, 489, 10.1186/s12891-016-1344-9 Katzberg, 2014, Prevalence of muscle cramps in patients with diabetes, Diabetes Care, 37, e17, 10.2337/dc13-1163 Ballout, 2017, Painful and prolonged muscle cramps following insulin injections in a patient with type 2 diabetes mellitus: revisiting the 1992 Duke Case, Front Endocrinol, 8, 243, 10.3389/fendo.2017.00243